Related Experiment Videos
Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids
F Mannello1, G Bocchiotti, G Bianchi
1Institute of Histology and Laboratory Analysis, University of Urbino, Italy.
Breast Cancer Research and Treatment
|January 1, 1996
Summary
Gross cystic breast disease in premenopausal women is linked to breast cancer risk. Researchers found prostate-specific antigen (PSA) is produced and accumulates in breast cyst fluid, particularly in active apocrine cysts.
Area of Science:
- Biochemistry
- Oncology
- Gynecology
Background:
- Gross cystic breast disease (GCBD) is common in premenopausal women.
- The composition of breast cyst fluid is crucial for understanding GCBD and potential breast cancer risk.
- Prostate-specific antigen (PSA) has been detected in breast tissue and tumors, but its role in GCBD is unclear.
Purpose of the Study:
- To investigate the presence and levels of prostate-specific antigen (PSA) in human breast cyst fluids.
- To determine if PSA levels differ between various types of breast cysts.
- To explore the potential role of PSA in the pathogenesis of GCBD.
Main Methods:
- Immuno-reactivity assays were used to measure PSA levels in 64 human breast cyst fluid samples.
- Statistical analysis was performed to compare PSA levels in different cyst types.
Main Results:
- 35% of samples had PSA levels below 0.05 micrograms/L.
- A significant increase in mean PSA levels was observed in metabolically active apocrine cysts compared to flattened cysts (p < 0.01).
- This study provides the first evidence of PSA production, secretion, and accumulation by the breast epithelium within gross cysts.
Conclusions:
- Breast epithelium in gross cysts actively produces, secretes, and accumulates significant amounts of PSA.
- Intracystic PSA accumulation in active apocrine cysts may play a role in GCBD development, cyst enlargement, and potential transformation.
- Further research into PSA's role in GCBD is warranted.